186 related articles for article (PubMed ID: 3264736)
1. The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes.
Evans SM; Collard KJ
Br J Pharmacol; 1988 Nov; 95(3):950-6. PubMed ID: 3264736
[TBL] [Abstract][Full Text] [Related]
2. On the mechanism by which extracellular sodium depletion causes 5-hydroxytryptamine release from rat brain synaptosomes.
Collard KJ
Biochim Biophys Acta; 1989 Sep; 984(3):319-25. PubMed ID: 2789079
[TBL] [Abstract][Full Text] [Related]
3. Effects of fluoxetine on basal and K(+)-induced tritium release from synaptosomes preloaded with [3H]serotonin.
Gobbi M; Crespi D; Mennini T
Life Sci; 1995; 56(10):785-91. PubMed ID: 7533873
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.
Stauderman KA; Gandhi VC; Jones DJ
Life Sci; 1992; 50(26):2125-38. PubMed ID: 1608295
[TBL] [Abstract][Full Text] [Related]
5. Interaction between 5-HT uptake inhibition and activation of 5-HT autoreceptors by exogenous agonists in rat cerebral cortex slices and synaptosomes.
Bonanno G; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):219-25. PubMed ID: 3473290
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of tetrahydroaminoacridine-evoked release of endogenous 5-hydroxytryptamine and dopamine from rat brain tissue prisms.
Robinson TN; De Souza RJ; Cross AJ; Green AR
Br J Pharmacol; 1989 Dec; 98(4):1127-36. PubMed ID: 2611486
[TBL] [Abstract][Full Text] [Related]
7. Evidence of an exocytotic-like release of [3H]5-hydroxytryptamine induced by d-fenfluramine in rat hippocampal synaptosomes.
Gobbi M; Frittoli E; Uslenghi A; Mennini T
Eur J Pharmacol; 1993 Jul; 238(1):9-17. PubMed ID: 8405087
[TBL] [Abstract][Full Text] [Related]
8. The effect of trifluoperazine and R 24 571 on the K+-evoked release of 5-hydroxytryptamine from superfused synaptosomes.
Leung MT; Collard KJ
Neuropharmacology; 1983 Sep; 22(9):1095-9. PubMed ID: 6633821
[TBL] [Abstract][Full Text] [Related]
9. The regulation of 5-hydroxytryptamine release from superfused synaptosomes by 5-hydroxytryptamine and its immediate precursors.
Suter HA; Collard KJ
Neurochem Res; 1983 Jun; 8(6):723-30. PubMed ID: 6604881
[TBL] [Abstract][Full Text] [Related]
10. Effect of in vitro inorganic lead on dopamine release from superfused rat striatal synaptosomes.
Minnema DJ; Greenland RD; Michaelson IA
Toxicol Appl Pharmacol; 1986 Jun; 84(2):400-11. PubMed ID: 3715885
[TBL] [Abstract][Full Text] [Related]
11. (-)-Trans-epsilon-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity.
Yáñez M; Fraiz N; Cano E; Orallo F
Eur J Pharmacol; 2006 Aug; 542(1-3):54-60. PubMed ID: 16828740
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine.
Gruetter CA; Lemke SM; Anestis DK; Szarek JL; Valentovic MA
Eur J Pharmacol; 1992 Jul; 217(2-3):109-18. PubMed ID: 1358631
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool.
Gobbi M; Parazzoli A; Mennini T
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):323-7. PubMed ID: 9774219
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of an autoreceptor modulating the release of [3H]5-hydroxytryptamine from a synaptosomal-rich spinal cord tissue preparation.
Monroe PJ; Smith DJ
J Neurochem; 1985 Dec; 45(6):1886-94. PubMed ID: 3877146
[TBL] [Abstract][Full Text] [Related]
15. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
Azzaro AJ; Amedro JB; Brown LM; Smith DJ; Williams GM
Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):9-13. PubMed ID: 2467212
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism by which tryptophan efflux from isolated synaptosomes is stimulated by depolarization.
Collard KJ; Wilkinson LS; Lewis DJ
Br J Pharmacol; 1988 Feb; 93(2):341-8. PubMed ID: 2965950
[TBL] [Abstract][Full Text] [Related]
17. The stimulus-induced release of 5-hydroxytryptamine and tryptophan from superfused rat brain synaptosomes.
Collard KJ; Evans TN; Suter HA; Wilkinson LS
J Neural Transm; 1982; 53(2-3):223-30. PubMed ID: 6176682
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
Savage DD; Mendels J; Frazer A
J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5,6-dihydroxytryptamine on the release, synthesis, and storage of serotonin: studies using rat brain synaptosomes.
Wolf WA; Bobik A
J Neurochem; 1988 Feb; 50(2):534-42. PubMed ID: 2447243
[TBL] [Abstract][Full Text] [Related]
20. Na(+)-Ca2+ exchange activity in central nerve endings. II. Relationship between pharmacological blockade by amiloride analogues and dopamine release from tuberoinfundibular hypothalamic neurons.
Taglialatela M; Canzoniero LM; Cragoe EJ; Di Renzo G; Annunziato L
Mol Pharmacol; 1990 Sep; 38(3):393-400. PubMed ID: 2402228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
